Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 4/20 | 0.59 |
| ▸ | MRGPRX4 | Q96LA9 | 5/20 | 0.56 |
| ▸ | BRD4 | O60885 | 1/20 | 0.55 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.51 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20463320 | 0.88 | MAOB (0.64) | MAOBMRGPRX4MEN1KMT2A | |
| SCHEMBL229472 | 0.88 | MRGPRX4 (0.69) | MRGPRX4PTGER1HPGDRAB9AS1PR5 | |
| SCHEMBL20463366 | 0.87 | MAOB (0.69) | MAOBMRGPRX4 | |
| SCHEMBL3123036 | 0.86 | MAOB (0.64) | MAOBMRGPRX4BRD4SMN1; SMN2NPC1 | |
| SCHEMBL3212402 | 0.85 | BRD4 (0.48) | MAOBMRGPRX4BRD4PTGER1SMN1; SMN2 | |
| SCHEMBL7711853 | 0.85 | MRGPRX4 (0.50) | MAOBMRGPRX4BRD4PTGER1SMN1; SMN2 | |
| SCHEMBL2744895 | 0.85 | PARP10 (0.59) | MAOBMRGPRX4PTGER1SMN1; SMN2NPC1 | |
| SCHEMBL31031135 | 0.85 | MRGPRX4 (0.56) | MRGPRX4BRD4PTGER1SMN1; SMN2NPC1 | |
| SCHEMBL8512056 | 0.85 | BRD4 (0.64) | MRGPRX4BRD4PTGER1SMN1; SMN2NPC1 | |
| SCHEMBL8512033 | 0.84 | SLC6A2 (0.57) | MRGPRX4PTGER1SMN1; SMN2NPC1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170080095-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | APOSENSE LTD. (IL) | 2017-03-23 | — | — | US | disclosed |
| US-20170037401-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | APOSENSE LTD. (IL) | 2017-02-09 | — | — | US | disclosed |
| US-8198305-B2 | 1-(4-(3-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)propoxy)-3-methoxy-d3-phenyl)ethanone substituted with deuterium ions; antipsycholtic agent | CONCERT PHARMACEUTICALS INC. (US) | 2012-06-12 | — | — | US | disclosed |
| US-8198305-B2 | 1-(4-(3-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)propoxy)-3-methoxy-d3-phenyl)ethanone substituted with deuterium ions; antipsycholtic agent | CONCERT PHARMACEUTICALS INC. (US) | 2012-06-12 | — | — | US | disclosed |
| WO-2008128166-A1 | DEUTERATED DERIVATIVES OF 4-(6-FLUORO-1, 2-BENZISOXAZOL-3-YL) PIPERIDINE COMPOUNDS | CONCERT PHARMACEUTICALS INC. (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080255194-A1 | 1,2-Benzisoxazol-3-yl Compounds | CONCERT PHARMACEUTICALS INC. (US) | 2008-10-16 | — | — | US | disclosed |
| US-20080255194-A1 | 1,2-Benzisoxazol-3-yl Compounds | CONCERT PHARMACEUTICALS INC. (US) | 2008-10-16 | — | — | US | disclosed |
| CN-1159797-A | Aryloxy and arylthiopropanolamine derivative suseful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof | SMITHKLINE BEECHAM PLC (GB) | 1997-09-17 | — | — | CN | disclosed |
| US-4649160-A | HYPOTENSIVE, ANTIARRHYTHMIA, ADRENERGIC BLOCKING AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1987-03-10 | — | — | US | disclosed |
| EP-0041233-B1 | SUBSTITUTED PHENOXY-AMINOPROPANOL DERIVATIVES, INTERMEDIATES AND PROCESSES FOR THEIR PRODUCTION, AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1984-02-15 | — | — | EP | disclosed |
| EP-0041233-A1 | Substituted phenoxy-aminopropanol derivatives, intermediates and processes for their production, and pharmaceutical preparations containing them | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-12-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170080095-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | ABCB4, LNPK, MBOAT1 | MAOB 3450/4885MRGPRX4 1223/4885BRD4 2982/4885 |
| US-20080255194-A1 | 1,2-Benzisoxazol-3-yl Compounds | HTR5A, HTR1A, HTR3A | MAOB 105/4885MRGPRX4 233/4885BRD4 242/4885 |
| US-20170037401-A1 | COMPOUNDS AND METHODS FOR TRANS-MEMBRANE DELIVERY OF MOLECULES | ABCB4, LNPK, MBOAT1 | MAOB 3450/4885MRGPRX4 1223/4885BRD4 2982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.